等待開盤 01-27 09:30:00 美东时间
-1.730
-9.33%
北水今日净卖出港股超6亿港元,腾讯、中国人寿分别获逆势加仓超10亿、5亿港元;中国移动遭净卖出超11亿港元>>
今天 18:13
US STOCKS-Wall Street indexes close higher ahead of earnings, Fed meeting Recasts with preliminary closing prices Communications, tech stocks rise ahead of key earnings USA Rare Earth jumps after reports of govt taking a 10% stake CoreWeave advances on Nvidia investment Prison stocks fall on backlas
今天 05:00
BUZZ-Prison operators GEO, CoreCivic down as Democrats to oppose DHS funding Updates ** Shares of prison operators GEO Group GEO.N and CoreCivic CXW.N down about 11.2 % and 9 % respectively ** Democrats in the Senate have said they will oppose a funding bill for the Department of Homeland Security,
今天 02:47
BUZZ-Prison operators GEO, CoreCivic down ** Shares of prison operators GEO Group GEO.N and CoreCivic CXW.N down 10.6% and 7.7% respectively ** Democrats in the Senate have said they will oppose a funding bill for the Department of Homeland Security, overseer of ICE ** This follows a fatal shooting
今天 02:28
The GEO Group (GEO) has finalized an amendment to its credit deal to increase its revolving credit facility commitments from $450M to $550M, effective January 20, 2026. George Zoley, executive chairma...
01-22 20:22
The GEO Group Expands Revolving Credit Facility to $550 Million The GEO Group Inc. has announced an amendment to its existing Amended Credit Agreement, increasing the company's Revolving Credit Facility commitments from $450 million to $550 million. The expanded facility, effective January 20, 2026,
01-22 19:55
The GEO Group (GEO) was awarded a contract by U.S. Immigration and Customs Enforcement ("ICE") to provide skip tracing services for up to two years, with an estimated revenue value of up to ~$121M ove...
2025-12-22 20:54
An update from Geo Group ( ($GEO) ) is now available. On November 13, 2025, The...
2025-11-18 19:57
Companies Reporting Before The Bell • Edgewell Personal Care (NYSE:EPC) is proj...
2025-11-13 19:11
今日重点评级关注:HC Wainwright & Co.:维持Adicet Bio"买入"评级,目标价从4美元升至9美元;Citizens: 维持Rapport Therapeutics"跑赢大市"评级,目标价从77美元升至80美元
2025-11-10 17:17